# Feasibility Trial of the Bios Device for Continuous Glucose Monitoring

> **NCT04226846** · — · UNKNOWN · sponsor: **GraphWear Technologies Inc.** · enrollment: 50 (estimated)

## Conditions studied

- Type 1 Diabetes
- Type 2 Diabetes

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04226846
- **Lead sponsor:** GraphWear Technologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-09
- **Primary completion:** 2020-03-15
- **Final completion:** 2020-03-15
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2020-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04226846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04226846, "Feasibility Trial of the Bios Device for Continuous Glucose Monitoring". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04226846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*